JP2008512465A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512465A5
JP2008512465A5 JP2007531283A JP2007531283A JP2008512465A5 JP 2008512465 A5 JP2008512465 A5 JP 2008512465A5 JP 2007531283 A JP2007531283 A JP 2007531283A JP 2007531283 A JP2007531283 A JP 2007531283A JP 2008512465 A5 JP2008512465 A5 JP 2008512465A5
Authority
JP
Japan
Prior art keywords
compound
hydrogen
compound according
thiazol
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007531283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512465A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/031786 external-priority patent/WO2006029179A2/en
Publication of JP2008512465A publication Critical patent/JP2008512465A/ja
Publication of JP2008512465A5 publication Critical patent/JP2008512465A5/ja
Pending legal-status Critical Current

Links

JP2007531283A 2004-09-08 2005-09-07 脂肪酸酸化阻害剤としての置換ピペラジン化合物およびその使用 Pending JP2008512465A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60838404P 2004-09-08 2004-09-08
PCT/US2005/031786 WO2006029179A2 (en) 2004-09-08 2005-09-07 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors

Publications (2)

Publication Number Publication Date
JP2008512465A JP2008512465A (ja) 2008-04-24
JP2008512465A5 true JP2008512465A5 (enExample) 2008-08-21

Family

ID=35884036

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007531283A Pending JP2008512465A (ja) 2004-09-08 2005-09-07 脂肪酸酸化阻害剤としての置換ピペラジン化合物およびその使用

Country Status (7)

Country Link
US (2) US7271169B2 (enExample)
EP (1) EP1789407A2 (enExample)
JP (1) JP2008512465A (enExample)
KR (1) KR20070051305A (enExample)
AU (1) AU2005282492A1 (enExample)
CA (1) CA2579621A1 (enExample)
WO (1) WO2006029179A2 (enExample)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2824764A1 (de) * 1978-06-06 1979-12-20 Hoechst Ag Neue pyridylpiperazinderivate und verfahren zu ihrer herstellung
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
US4558129A (en) 1983-05-18 1985-12-10 Syntex (U.S.A.) Inc. Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade
US4567264A (en) * 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
US4588129A (en) * 1983-09-06 1986-05-13 Hudson Oxygen Therapy Sales Company Nebulizer
DE3614355A1 (de) * 1986-04-28 1987-10-29 Hoechst Ag Neue benzothiazinon-derivate, verfahren zu ihrer herstellung , sie enthaltende arzneimittel und deren verwendung
DE69033967T2 (de) * 1989-06-23 2002-12-19 Syntex (U.S.A.) Llc, Palo Alto Ranolazin und verwandte Piperazine zur Behandlung von Schockzuständen
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
AU2001238590A1 (en) * 2000-02-22 2001-09-03 Cv Therapeutics, Inc. Substituted piperazine compounds
US6552023B2 (en) * 2000-02-22 2003-04-22 Cv Therapeutics, Inc. Aralkyl substituted piperazine compounds
WO2001062711A2 (en) * 2000-02-22 2001-08-30 Cv Therapeutics, Inc. Substituted alkylene diamine compounds
US6451798B2 (en) * 2000-02-22 2002-09-17 Cv Therapeutics, Inc. Substituted alkyl piperazine derivatives
WO2001062744A2 (en) * 2000-02-22 2001-08-30 Cv Therapeutics, Inc. Substituted piperazine compounds
US6677336B2 (en) * 2000-02-22 2004-01-13 Cv Therapeutics, Inc. Substituted piperazine compounds
US6573264B1 (en) * 2000-10-23 2003-06-03 Cv Therapeutics, Inc. Heteroaryl alkyl piperazine derivatives
US7001909B2 (en) * 2001-07-19 2006-02-21 Cv Therapeutics, Inc. Substituted heterocyclic compounds
ATE292633T1 (de) * 2001-07-19 2005-04-15 Cv Therapeutics Inc Substituierte piperazinderivate und ihre verwendung als fettsaüreoxidationsinhibitoren
US6638870B2 (en) * 2002-01-10 2003-10-28 Infineon Technologies Ag Forming a structure on a wafer
CN1181065C (zh) * 2002-05-08 2004-12-22 上海医药工业研究院 芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
DE60328545D1 (de) * 2002-12-05 2009-09-03 Cv Therapeutics Inc Substituierte Piperazinderivate und ihre Verwendung als Inhibitoren der Fettsäureoxidation
KR20050092424A (ko) * 2003-01-17 2005-09-21 씨브이 쎄러퓨틱스, 인코포레이티드 심혈관 질환의 치료에 유용한 치환된 헤테로고리 화합물

Similar Documents

Publication Publication Date Title
KR101179087B1 (ko) 인간 단백질 티로신 포스파타아제 억제제 및 이용 방법
JP6017313B2 (ja) 化合物および方法
JP2013517283A5 (enExample)
JP2006519258A5 (enExample)
JP2007536224A5 (enExample)
JP2004527503A5 (enExample)
JP2004534035A5 (enExample)
JP2010506825A5 (enExample)
JP2013506637A5 (enExample)
JP2010526025A5 (enExample)
JP2008507532A5 (enExample)
JP2008517945A5 (enExample)
JP2010540462A5 (enExample)
JP2013519680A5 (enExample)
JP2014523901A5 (enExample)
JP2004509953A5 (enExample)
RU2006123559A (ru) Биарилсульфонамиды в качестве ммр-ингибиторов
JP2007511485A5 (enExample)
JP2006500369A5 (enExample)
JP2004537554A5 (enExample)
RU2004104951A (ru) Замещенные пиперазиновые соединения и их применение в качестве ингибиторов окисления жирных кислот
WO2003064376A1 (en) Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
AU2003239296A1 (en) Substituted methylene amide derivatives as Modulators of Protein Tyrosine Phosphatases (PTPs)
JP2006522797A5 (enExample)
JP2005526732A5 (enExample)